U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                         AMENDMENT NO. 2 TO FORM 10-QSB

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

                  For the quarterly period ended April 30, 2005

    [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934

                         For the transition period from

                          Commission File No. 000-51509

                                 Elite Cosmetics, Inc.
        (Exact name of small business issuer as specified in its charter)

       Delaware                                             68-0605151
(State or other jurisdiction of                         (I.R.S. Employer
incorporation or organization)                          Identification No.)

                            107 St. Patrick's Street
                            Donaldsonville, Louisiana 70346
                    (Address of Principal Executive Offices)

                                  225/473-7578
                           (Issuer's telephone number)

                                    EDMONDS 4, INC.
                             300 Park Avenue, #1700
                            New York, New York 10022
      (Former name, address and fiscal year, if changed since last report)

Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for
such shorter period that the issuer was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Yes [X] No [ ]



State the number of shares outstanding of each of the issuer's classes of common
equity, as of June 16, 2005: 28,870,000 shares of common stock.

<PAGE>


                              Elite Cosmetics, Inc.
                          (a development stage company)

                              FINANCIAL STATEMENTS

                                      INDEX


Part I-- FINANCIAL INFORMATION

  Item 1. Financial Statements

  Item 2. Management's Discussion and Analysis of Financial Condition

  Item 3. Control and Procedures

Part II-- OTHER INFORMATION

  Item 1. Legal Proceedings

  Item 2. Changes in Securities

  Item 3. Defaults Upon Senior Securities

  Item 4. Submission of Matters to a Vote of Security Holders

  Item 5. Other Information

  Item 6. Exhibits and Reports on Form 8-K

Signature

<PAGE>

Item 1. Financial Information

BASIS OF PRESENTATION

The accompanying reviewed financial statements are presented in accordance with
U.S. generally accepted accounting principles for interim financial information
and the instructions to Form 10-QSB and item 310 under subpart A of Regulation
S-B. Accordingly, they do not include all of the information and footnotes
required by generally accepted accounting principles for complete financial
statements. In the opinion of management, all adjustments (consisting only of
normal occurring accruals) considered necessary in order to make the financial
statements not misleading, have been included. Operating results for the six
months ended April 30, 2005 are not necessarily indicative of results that may
be expected for the year ending October 31, 2005. The financial statements are
presented on the accrual basis.


<PAGE>
                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                              FINANCIAL STATEMENTS
                              AS OF APRIL 30, 2005
                                   (UNAUDITED)



<PAGE>



                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)



                                    CONTENTS


PAGE            1       CONDENSED BALANCE SHEET AS OF APRIL 30, 2005 (UNAUDITED)

PAGE            2       CONDENSED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX
                        MONTHS  ENDED  APRIL 30,  2005 AND FOR THE  PERIOD  FROM
                        AUGUST  19,   2004   (INCEPTION)   TO  APRIL  30,   2005
                        (UNAUDITED)

PAGE            3       CONDENSED  STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
                        FOR THE PERIOD FROM AUGUST 19, 2004 (INCEPTION) TO APRIL
                        30, 2005 (UNAUDITED)

PAGE            4       CONDENSED  STATEMENTS  OF CASH  FLOWS FOR THE SIX MONTHS
                        ENDED  APRIL 30, 2005 AND FOR THE PERIOD FROM AUGUST 19,
                        2004 (INCEPTION) TO APRIL 30, 2005 (UNAUDITED)

PAGES        5 - 7      NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

<PAGE>

                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                             CONDENSED BALANCE SHEET
                              AS OF APRIL 30, 2005
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                                     ASSETS

<S>                                                                                    <C>
CURRENT ASSETS
  Cash                                                                             $        4,500
                                                                                   ---------------

TOTAL ASSETS                                                                       $        4,500
                                                                                   ===============

                                      LIABILITIES AND STOCKHOLDERS' EQUITY

TOTAL LIABILITIES                                                                  $            -

STOCKHOLDERS' EQUITY
  Common stock, $0.0001 par value, 100,000,000 shares authorized, 28,650,000 shares
   issued and outstanding                                                                   2,865
  Additional paid in capital                                                              854,485
  Accumulated deficit during development stage                                           (852,850)
                                                                                   ---------------
        Total Stockholders' Equity                                                          4,500
                                                                                   ---------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                         $        4,500
                                                                                   ===============
</TABLE>

            See accompanying notes to condensed financial statements.

                                        1
<PAGE>


                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                       CONDENSED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)


<TABLE>
<CAPTION>


                                                       For the Three Months       For the Six Months For the PeriodFrom
                                                                                                        August 19,2004
                                                                Ended                     Ended      Inception) toApril
                                                           April 30, 2005            April 30, 2005        30, 2005
                                                        ------------------        ------------------  ------------------

<S>                                                          <C>                         <C>                   <C>
    OPERATING EXPENSES
      Stock compensation                                $         852,000         $         852,000   $         852,000
      General and administrative                                        -                       250                 850
                                                        ------------------        ------------------  ------------------
            Total Operating Expenses                              852,000                   852,250             852,850
                                                        ------------------        ------------------  ------------------

    LOSS FROM OPERATIONS                                         (852,000)                 (852,250)           (852,850)

    Provision for Income Taxes                                          -                         -                   -
                                                        ------------------        ------------------  ------------------

    NET LOSS                                            $        (852,000)        $        (852,250)  $        (852,850)
                                                        ==================        ==================  ==================

     Net loss per share - basic and diluted             $           (0.85)   `                (0.85)  $           (0.85)
                                                        ==================        ==================  ==================

    Weighted average number of shares outstanding
     during the period - basic and diluted                      1,007,528                 1,003,702           1,002,638
                                                        ==================        ==================  ==================
</TABLE>


            See accompanying notes to condensed financial statements.


                                        2
<PAGE>



                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                  CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
        FOR THE PERIOD FROM AUGUST 19, 2004 (INCEPTION) TO APRIL 30, 2005
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                                                                                  Accumulated
                                                                                Additional       Deficit During
                                                  Common Stock                  Paid-In          Development
                                            Shares            Amount            Capital              Stage               Total
                                       ----------------  ----------------    ----------------   ----------------    ----------------
<S>                                        <C>                  <C>                <C>                <C>
Stock issued to founders for expenses
 ($0.0001 per share)                           100,000   $            10     $            90    $             -     $           100

Net loss for the period from August 19,
 2004 (inception) to October 31, 2004                -                 -                   -               (600)               (600)
                                       ----------------  ----------------    ----------------   ----------------    ----------------

Balance, October 31, 2004                      100,000                10                  90               (600)               (500)

Common stock issued for services
 ($0.03 per share)                          28,400,000             2,840             849,160                  -             852,000

Common stock issued for cash
 ($0.03 per share)                             150,000                15               4,485                  -               4,500

In-kind contribution                                 -                 -                 750                  -                 750

Net loss for the six months
 ended April 30, 2005                                -                 -                   -           (852,250)
(852,250)
                                       ----------------  ----------------    ----------------   ----------------    ----------------

BALANCE, APRIL 30, 2005                     28,650,000   $         2,865     $       854,485           (852,850)              4,500
                                       ================  ================    ================   ================    ================
</TABLE>

            See accompanying notes to condensed financial statements.


                                        3
<PAGE>

                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                       CONDENSED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                              For the Six Months         For the Period From
                                                                                                           August 19,2004
                                                                                    Ended                   (Inception)to
                                                                                April 30, 2005              April 30, 2005
                                                                             ---------------------      ---------------------

<S>                                                                                  <C>                          <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net loss                                                                   $           (852,250)       $          (852,850)
  Adjustments to reconcile net loss to net cash used in operating activities:
    Stock compensation                                                                    852,000                    852,100
    In-kind contribution                                                                      750                        750
   Changes in operating assets and liabilities:
    Decrease in accounts payable                                                             (500)                         -
                                                                             ---------------------      ---------------------
         Net Cash Used In Operating Activities                                                  -                          -
                                                                             ---------------------      ---------------------

CASH FLOWS FROM INVESTING ACTIVITIES                                                            -                          -
                                                                             ---------------------      ---------------------

CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from issuance of common stock                                                    4,500                      4,500
                                                                             ---------------------      ---------------------
         Net Cash Provided By Financing Activities                                          4,500                      4,500
                                                                             ---------------------      ---------------------

NET INCREASE IN CASH                                                                        4,500                      4,500

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD                                                -                          -
                                                                             ---------------------      ---------------------

CASH AND CASH EQUIVALENTS AT END OF PERIOD                                   $              4,500       $              4,500
                                                                             =====================      =====================
</TABLE>


            See accompanying notes to condensed financial statements.


                                        4
<PAGE>

                              ELITE COSMETICS, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                              AS OF APRIL 30, 2005
                                   (UNAUDITED)


NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

     (A) Basis of Presentation

     The accompanying unaudited condensed financial statements have been
     prepared in accordance with accounting principles generally accepted in The
     United States of America and the rules and regulations of the Securities
     and Exchange Commission for interim financial information. Accordingly,
     they do not include all the information necessary for a comprehensive
     presentation of financial position and results of operations.

     It is management's opinion, however that all material adjustments
     (consisting of normal recurring adjustments) have been made which are
     necessary for a fair financial statements presentation. The results for the
     interim period are not necessarily indicative of the results to be expected
     for the year.

     During  2005,  the Company  changed its name from  Edmonds 4, Inc. to Elite
     Cosmetics, Inc. to better reflect its current business operations.

     (B) Organization

     Elite Cosmetics,  Inc. F/K/A Edmonds 4, Inc. (a development  stage company)
     (the  "Company") was  incorporated  in Delaware on August 19, 2004, and has
     elected a fiscal year end of October 31.

     The Company plans to market a lime of women's' cosmetics. The Company
     intends to market its products directly to consumers through a variety of
     direct marketing channels.

     Activities during the development stage include developing the corporate
     infrastructure, implementing the business plan, and raising capital.

     (C) Use of Estimates

     In preparing financial statements in conformity with generally accepted
     accounting principles, management is required to make estimates and
     assumptions that affect the reported amounts of assets and liabilities and
     the disclosure of contingent assets and liabilities at the date of the
     financial statements and revenues and expenses during the reported period.
     Actual results could differ from those estimates.

                                        5
<PAGE>
     (D) Loss Per Share

     Basic and diluted net loss per common share is computed based upon the
     weighted average common shares outstanding as defined by Financial
     Accounting Standards No. 128, "Earnings Per Share." As of April 30, 2005,
     there were no common share equivalents outstanding.

     (E) Business Segments

     The Company operates in one segment and therefore segment information is
     not presented.

     (F) Income Taxes

     The Company accounts for income taxes under the Statement of Financial
     Accounting Standards Board Statement of Financial Accounting Standards No.
     109, "Accounting for Income Taxes" ("Statement 109"). Under Statement 109,
     deferred tax assets and liabilities are recognized for the future tax
     consequences attributable to differences between the financial statement
     carrying amounts of existing assets and liabilities and their respective
     tax bases. Deferred tax assets and liabilities are measured using enacted
     tax rates expected to apply to taxable income in the years in which those
     temporary differences are expected to be recovered or settled. Under
     Statement 109, the effect on deferred tax assets and liabilities of a
     change in tax rates is recognized in income in the period that includes the
     enactment date.

NOTE 2 STOCKHOLDERS' EQUITY

     (A) Common Stock Issued for Cash

     During April 2005, the Company issued 150,000 shares of common stock to
     individuals for cash of $4,500 ($0.03 per share).

     (B) Stock Issued for Services

     During 2004, the Company issued 100,000 shares of common stock to its
     founder for payment of $100 in expenses ($0.0001 per share).

     During 2005, the Company issued 28,400,000 shares of common stock to its
     principal stockholder for services valued at $852,000 based on recent cash
     offering prices ($0.03 per share) (See Note 3).

                                        6
<PAGE>

     (D) In-Kind Contribution

     During 2005, the principal stockholder of the Company paid $750 of
     operating expenses on behalf of the Company (See Note 3).

NOTE 3 RELATED PARTY TRANSACTIONS

     A principal stockholder of the Company paid $750 of expenses on behalf of
     the Company from inception (See Note 2).

     During 2005, the Company issued 28,400,000 shares of common stock to its
     principal stockholder for services valued at $852,000 based on recent cash
     offering prices ($0.03 per share) (See Note 2).

NOTE 4 GOING CONCERN

     As reflected in the accompanying financial statements, the Company is in
     the development stage with no operations. This raises substantial doubt
     about its ability to continue as a going concern. The ability of the
     Company to continue as a going concern is dependent on the Company's
     ability to raise additional capital and implement its business plan. The
     financial statements do not include any adjustments that might be necessary
     if the Company is unable to continue as a going concern.

     Management believes that actions presently being taken to obtain additional
     funding and implement its strategic plans provide the opportunity for the
     Company to continue as a going concern.

NOTE 5 SUBSEQUENT EVENT

     During May 2005, the Company issued 220,000 shares of common stock to
     individuals for cash of $6,600 ($0.03 per share).

                                        7
<PAGE>
Item 2. Management's Discussion and Analysis of Financial Conditions and Results
        of Operations

Plan of Operation

On March 25, 2005 (the "Effective Date"), pursuant to the terms of a Stock
Purchase Agreement, Glen Landry purchased 100,000 shares of our issued and
outstanding common stock from Richard Neussler, the sole officer, director and
shareholder of the Company. Glen Landry was appointed our President, Chief
Executive Officer, Chief Financial Officer, and Chairman of the Board of
Directors. As a result of this change in control, we have changed our business
plan to the production of cosmetics and creams. Specifically we will begin the
development and production of an under-eye cream as well as the development of
other cosmetic products in the future. On April 8, 2005, we amended our Articles
of Incorporation to change our name to Elite Cosmetics, Inc.


During the next twelve months, we expect to take the following steps in
connection with the further development of our business and the implementation
of our plan of operations:

    * Prepare and execute a marketing plan to increase our sales of cosmetics.
We presently have a web page listed at www.elitecosmetics.net with 3 products on
it. Within thirty to sixty days, we intend to develop a comprehensive marketing
plan through the efforts of our president Mr. Landry. However, if we are
operating at a profit, we will consider hiring a consultant to expand and
improve on our marketing plan. We expect to spend approximately $10,000 on
marketing in the fourth quarter of 2005, primarily in the areas of advertising
and sponsored links through Google, Yahoo, and other similar targeted keyword
programs. We also anticipate advertising on internet radio web pages such as
http://cfrn.net/, http://ibcradio.com/, and others. Although we currently do not
have enough cash to satisfy this objective, our President and CEO Glen Landry
has agreed to loan us the money.

    * In ninety days we anticipate implementing a major upgrade to the
www.elitecosmetics.net website. We have already had some initial discussions
with several programmers about enhancements that can be made to the website such
as selling our cosmetics directly through our web page, as oppose to
distributing our product via Ebay. Such an upgrade would cost approximately
$2,000 to $2,500, and would be paid out of the funds raised in our private
placement.

    * In the fourth quarter of 2005, we intend to develop additional cosmetics,
such as lip plumpers and lip gloss through the efforts of Mr. Landry and his
wife. We hope to launch several other websites as well. With the help of web
programmers, we believe we can launch one to three additional websites within
six to nine months for a cost of $5,000 to $10,000. We will work to enter into
negotiations with other companies such as Wal-Mart, K-Mark, Walgreens, and so
on. To date, we have not entered into any discussions with such vendors.

     * By early 2006 will make efforts to form partnership programs, where we
will sell our cosmetics at a wholesale price to larger corporations, who in turn
will distribute our products to their customers. However, we have not yet
entered into any negotiations regarding such programs.

     * By early 2006 we intend to hire a cosmetologist to assist in the
development of more cosmetics. We anticipate paying either an annual salary, or
hourly fee to a dedicated cosmetologist based upon the workload required.

    * In early 2006 we anticipate establishing a mailing list of loyal customers
and over the counter cosmetic vendors.

Completion of our plan of operations is subject to attaining adequate revenue.
We cannot assure investors that adequate revenues will be generated. We will
need a minimum of $100,000 to commence our planned operations and an additional
amount of $200,000 to execute our business plan over the next twelve months. We
currently do not have enough cash to satisfy our minimum cash requirements for
the next twelve months to maintain our operations. Over the next twelve months
we expect to spend $55,000 for marketing and advertising expenses such as
acquiring billboards and on-line advertising on websites such as Ebay, Yahoo!,
MSN, and Cox.net. Additionally, $40,000 will be allocated for professional fees
such as accounting fees, filing fees, and legal fees. We will also require
$50,000 for office supplies, computer upgrades, and cosmetics supplies. We
anticipate that $55,000 will be necessary for costs related to website
development, hosting, search engine submission, and ongoing maintenance. We
expect to allocate $100,000 to working capital and for product research and
development. In the event that we are unable to raise an amount necessary to
cover all of the aforementioned uses, we anticipate our expenditures related to
advertising, supplies, research and development, and working capital will vary
accordingly.

Results of Operation

We did not have any operating income from inception (August 19, 2004) through
April 30, 2005 and during this period we recognized a net loss of $852,850. We
have had no general and administrative expenses from inception. Our expenses
from inception were comprised of stock compensation paid to our sole officer and
director.

                                        8
<PAGE>

Liquidity and Capital Resources

At April 30, 2005 the Company had $4,500 in cash and total assets, and will rely
upon the issuance of common stock and additional capital contributions from
shareholders to fund administrative expenses pending the commencement of our
operations.

In April 2005, we conducted a private placement offering and issued 150,000
shares of common stock at a purchase price of $0.03 per share to individuals for
total cash of $4,500.


Item 3. Controls and Procedures

(a) Evaluation of disclosure controls and procedures.

Our Chief Executive Officer and Chief Financial Officer (collectively the
"Certifying Officers") maintain a system of disclosure controls and procedures
that is designed to provide reasonable assurance that information, which is
required to be disclosed, is accumulated and communicated to management timely.
Under the supervision and with the participation of management, the Certifying
Officers evaluated the effectiveness of the design and operation of our
disclosure controls and procedures (as defined in Rule [13a-14(c)/15d-14(c)]
under the Exchange Act) within 90 days prior to the filing date of this report.
Based upon that evaluation, the Certifying Officers concluded that our
disclosure controls and procedures are effective in timely alerting them to
material information relative to our company required to be disclosed in our
periodic filings with the SEC.

(b) Changes in internal controls.

Our Certifying Officer has indicated that there were no significant changes in
our internal controls or other factors that could affect such controls
subsequent to the date of his evaluation, and there were no such control actions
with regard to significant deficiencies and material weaknesses.

                           PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.

          We are currently not a party to any pending legal proceedings and no
          such action by, or to the best of its knowledge, against the us has
          been threatened.

Item 2.   Changes in Securities.

          None

Item 3.   Defaults Upon Senior Securities.

          None

Item 4.   Submission of Matters to a Vote of Security
          Holders.

          No matter was submitted during the quarter ending April 30, 2005,
          covered by this report to a vote of our shareholders, through the
          solicitation of proxies or otherwise.

Item 5.   Other Information.

          None

Item 6.   Exhibits and Reports of Form 8-K.

          (a)  Exhibits

          31.1 Certification pursuant to Section 302 of Sarbanes Oxley Act
               of 2002

          32.1 Certification pursuant to Section 906 of Sarbanes Oxley Act
               of 2002

          (b) Reports of Form 8-K

              On April 5, 2005, we filed a Form 8-K pursuant to a change in
              control.


                                        9

<PAGE>


                                   SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, there unto
duly authorized.

                                 Elite Cosmetics, Inc.

Date: October 18, 2005           By: /s/ Glen Landry
                                 ----------------------
                                 Glen Landry
                                 President, CEO and CFO





                                       10